Mission-Critical Services Enabled by Core Capabilities in:

Strategic Alternatives Analysis

Today’s reality requires a nuanced understanding of the markets, regulatory trends and competitor landscape informed by industry experience, critical thinking and rigorous analysis. To drive committed investment decisions, your firm’s source of differentiation must be matched to pressure-tested business goals and the optimal path to achieve them. Proaltus works with its clients to develop strategies that seamlessly flow into execution:

Corporate-level goal setting and execution roadmaps

• Strategic alternatives identification and analysis
  

• Engagement with management team and internal stakeholders
  

• Engagement with key stakeholders, including investors, boards, and key customers
  

Portfolio or technology platform investment

• Identify relevant trends that affect the value of the portfolio or technology platform
  

• Identify new or adjacent growth opportunities
  

• Insight and analysis to maximize optionality

Commercial Asset Assessment

All too often, assets with uncompetitive, poorly differentiated or low value profiles that could have been intercepted early and redirected pass a loosely defined, ill-considered proof of concept definition and progress to an expensive late stage clinical registration program. A more competitive product environment, coupled with payer cost containment practices, is driving pharma to employ a more critical and rigorous examination of product strategy to support key investment decisions from early stage development through commitment to launch. Backed by a mix of extensive commercial skills, abilities and leadership experience, as well as a dynamic insight market research capability, Proaltus assesses the commercial prospects of development stage assets and synthesizes product strategy to support sound commercial and clinical development investment decisions:

• Broad-scope, forward looking commercial landscape assessments of the target launch window including patient, provider and payer perspectives
• Comprehensive competitive analysis and differentiation strategies
• Proof of concept profile identification and validation
• Market entry strategies for established and emerging markets
• Pricing, reimbursement and access strategies
• Product forecasts and asset valuations

Licensing Out Campaign Solutions™

The partnering environment is more competitive than ever with 1,000’s of opportunities chasing a select number of highly discerning buyers. A successful business development strategy begins with a thoughtful corporate strategy; a partnering pitch must have both a compelling value proposition and the ability to survive the high-attrition evaluation and diligence process performed by potential licensees. Informed by decades of successes on both the buy and sell side of biopharma partnering, Proaltus has developed an integrated and comprehensive approach to deal preparation called “Licensing Out Campaign Solutions™.

LOCS™ is composed of inter-related elements developed in logical sequence:

• Disease and Product Dossiers
  

• Commercial Assessment
  

• Valuation Model
  

• Term Sheet Template
  

• Partnering Collateral
  

• Partnering Strategy
  

• Negotiation Prep